Mike Morrissey

CEO

Equibles does not estimate personal net worth.

Get an email with a short summary when Exelixis, Inc. publishes a filing, an earnings call transcript or a press release.

Get EXEL alerts

About Mike Morrissey

Mike Morrissey is recorded as CEO at Exelixis, Inc. (EXEL). Mike Morrissey has spoken on 12 earnings calls across 1 company, most recently for Exelixis, Inc. on December 31, 2024. Exelixis, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Exelixis, Inc. includes Michael M. Morrissey (CEO and Board Member), Michael Morrissey (CEO and Board Member), Christopher Senner (CFO) and 7 others.

Mike Morrissey on recent calls

“Exelixis had a breakout year in 2024, and we're already sprinting into 2025 after a busy January, where we provided important updates across all components of our business.”

CEO, Exelixis, Inc. Q4 FY2024 Earnings Call · December 31, 2024

“Exelixis had a strong year in 2023 and we're already sprinting into 2024 after a busy January where we provided important updates across literally all components of our business.”

CEO, Exelixis, Inc. Q4 FY2023 Earnings Call · December 31, 2023

“And thanks to everyone for joining us on the call today. Exelixis had a strong and very active third quarter across all components of our business.”

CEO, Exelixis, Inc. Q3 FY2023 Earnings Call · November 1, 2023

“Exelixis had a strong first quarter across all components of our business. CABOMETYX maintained its status as the leading TKI for RCC in both the first-line I-O TKI market and the second-line monotherapy segment.”

CEO, Exelixis, Inc. Q1 FY2023 Earnings Call · May 9, 2023